1. Scrip
  2. >>Business

MSD's COVID-19 Pill Molnupiravir Gains First Approval In UK

To Be Marketed As Lagevrio

 
• By Andrew McConaghie

The UK becomes the first country to grant a marketing authorization for the oral treatment which could help cut hospitalizations and deaths by half.

Merck_New_Jersey
The UK has seized the chance of being first to approve the oral COVID-19 drug, though details of how the treatment will be made available on the NHS are still being decided. • Source: Alamy

The UK has become the first country in the world to grant marketing authorization to MSD's molnupiravir, the first oral therapy for COVID-19, to be sold as Lagevrio.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) announced its decision on 4 November and said the antiviral was safe and effective at reducing the risk of hospitalization and death in people with mild

More from Business

More from Scrip